Douglas S McCorkle Net Worth & Insider Trades

Douglas S McCorkle - VP Controller and Asst Treasur, Regeneron Pharmaceuticals Inc

As of December 29, 2015

What is Douglas S McCorkle's Net Worth?

The current estimated net worth of Regeneron Pharmaceuticals Inc's VP Controller and Asst Treasur, Douglas S McCorkle, is estimated to be about $31.09M . Douglas S McCorkle owns about 10,995 units of Regeneron Pharmaceuticals Inc common stock. In the last 8 years at Regeneron Pharmaceuticals Inc, Douglas S McCorkle has sold an estimated value of $31.45M worth.

What is Douglas S McCorkle's Past Insider Trading?

Douglas S McCorkle's largest purchase order was 13,464 units , worth over $2.34M on May 26, 2015. Douglas S McCorkle's largest sale order was 13,000 units , worth over $6.7M on May 26, 2015. In total, Douglas S McCorkle has made about 31 transactions over 8 years of their time at Regeneron Pharmaceuticals Inc. Douglas S McCorkle usually trades in December, with the busiest year in 2014. The most recent transaction was a sale order of 3,954 units , worth over $2.18M on December 29, 2015.

Douglas S McCorkle

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Douglas S McCorkle's' Mailing Address?

  • Mailing address is Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown NY 10591 NY

Regeneron Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Stock Awards
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Compensation
Total
Leonard S. Schleifer, M.D., Ph.D. 2020 $1,480,119 $130,000,032 $3,567,714 $3,567,714 $302,256 $135,350,121
Leonard S. Schleifer, M.D., Ph.D. 2019 $1,377,100 $4,983,226 $3,057,162 $3,057,162 $338,043 $21,455,117
Leonard S. Schleifer, M.D., Ph.D. 2018 $1,330,500 - $2,953,710 $2,953,710 $896,432 $26,520,555
George D. Yancopoulos, M.D., Ph.D. 2020 $1,258,096 $130,000,032 $3,004,391 $3,004,391 $120,800 $134,383,319
George D. Yancopoulos, M.D., Ph.D. 2019 $1,170,500 $4,983,226 $2,598,510 $2,598,510 $212,313 $20,664,135
George D. Yancopoulos, M.D., Ph.D. 2018 $1,130,900 - $2,510,598 $2,510,598 $399,718 $25,381,129
Robert E. Landry 2020 $825,577 $949,560 $938,872 $938,872 $24,195 $6,197,703
Robert E. Landry 2019 $730,000 $2,840,008 $811,395 $811,395 $23,470 $7,931,542
Robert E. Landry 2018 $680,000 $4,767,500 $581,400 $581,400 $19,535 $9,356,619
Daniel P. Van Plew 2020 $825,577 $3,409,560 $938,872 $938,872 $20,945 $8,654,453
Daniel P. Van Plew 2019 $683,100 $2,840,008 $759,266 $759,266 $20,470 $7,829,513
Daniel P. Van Plew 2018 $660,000 - $677,160 $677,160 $19,915 $9,007,222
Andrew J. Murphy, Ph.D. 2020 $726,923 $5,025,288 $887,250 $887,250 $24,195 $10,998,914
Andrew J. Murphy, Ph.D. 2019 $600,000 $4,702,308 $666,900 $666,900 $23,470 $9,519,347
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/872589/000093041321000869/c101011_def14a.htm

What are Regeneron Pharmaceuticals Inc's Past Insider Trades?

Regeneron Pharmaceuticals Inc's most recent insider trade came on December 2, 2022 by Arthur F Ryan who sold 100 units worth $75.82K . In the last 19 years, insiders at Regeneron Pharmaceuticals Inc have sold an estimated value of $17.48B and bought an estimated value of $3.51B worth of shares. Insider trading is most common in December, with the busiest year in 2014. The most active traders at the company are Joseph L Goldstein, Director,  Michael S Brown, Director,  and P. Roy Vagelos, Director .

REGENERON PHARMACEUTICALS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1